Francine Kaufman, Chief Medical Officer and Director at Senseonics Holdings, Inc., filed a statement of changes in beneficial ownership on November 17, 2026, reporting a disposition of common stock on November 15, 2026.

Key Highlights

  • Reporting person: Francine Kaufman, serving as both Director and Chief Medical Officer of Senseonics Holdings, Inc.
  • Shares disposed: 10,068 shares of common stock were withheld at a price of $10.58 per share on November 15, 2026.
  • Disposition code: The transaction was coded "F," indicating shares withheld by the company for tax obligations upon RSU vesting.
  • Remaining holdings: Following the transaction, Kaufman directly held 166,989 shares of common stock.
  • No open-market sale: According to the filing, the disposition "does not represent a sale of shares by the Reporting Person into the market."

Senseonics CMO Kaufman Reports Automatic Share Withholding on RSU Vesting

Senseonics Holdings, Inc. (NASDAQ:SENS), a medical technology company focused on continuous glucose monitoring systems, was the subject of a beneficial ownership filing by Francine Kaufman, its Chief Medical Officer and a member of its Board of Directors. The filing, submitted on November 17, 2026, covers a transaction dated November 15, 2026, in which 10,068 shares of common stock were disposed of at $10.58 per share.

According to the filing, the disposition arose from an automatic share withholding mechanism triggered by the vesting of restricted stock units. The filing states that the shares were "automatically withheld by the Company to satisfy tax withholding obligations arising upon the vesting of restricted stock units," and explicitly notes the transaction does not represent a market sale by Kaufman. Following the withholding, Kaufman's direct beneficial ownership in Senseonics common stock stood at 166,989 shares, as reported in Table I of the filing. No derivative securities transactions were reported in Table II.

The filing was signed by Frederick T. Sullivan as Attorney-in-Fact on November 17, 2026, and was filed by one reporting person. No amendment date was indicated, suggesting this was an original filing rather than a revision to a prior submission.

What Was Disclosed

Francine Kaufman, Chief Medical Officer and Director at Senseonics Holdings, Inc., reported a tax-related withholding of 10,068 common shares at $10.58 per share on November 15, 2026, leaving her with direct beneficial ownership of 166,989 shares.